Review and report of the role of Breast Milk Stem Cell in balancing immunomodulation after cardio pulmonary bypass

Young infants and newborn babies born with cardiac malformations have to undergo complex cardiac surgery with cardiopulmonary bypass in order to survive. The developmental stage of immune function in these cachectic infants and the cytokine and inflammatory storm that ensues after prolonged cardiopulmonary bypass, predisposes them to sepsis syndrome and multiorgan dysfunction in the immediate postoperative period as well as in the short term.1,2